Statement Of Cash Flows [Abstract]

Redcare Pharmacy N.V. - Filing #2154233

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
47 ,9 6 3 EUR
1 2 , 1 3 1 EUR
Increase (decrease) in working capital
13,493,000 EUR
16 , 9 8 1 EUR
Adjustments for decrease (increase) in trade and other receivables
20 ,3 16 EUR
2 , 27 7 EUR
Adjustments for increase (decrease) in trade and other payables
56,814,000 EUR
1 2 , 24 5 EUR
Adjustments for increase (decrease) in other liabilities
6,408,000 EUR
625,000 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) decrease (increase) in restricted cash and cash equivalents
4,234,000 EUR
1,4 12 EUR
Dividends received from associates, classified as investing activities
19 0 EUR
0 EUR
Cash receipts from repayment of advances and loans made to related parties
0 EUR
300,000 EUR
Cash flows from (used in) decrease (increase) in short-term deposits and investments
41,125,000 EUR
80,493,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from exercise of options
2,64 6 EUR
637,000 EUR
Proceeds from non-current borrowings
0 EUR
0 EUR
Repayments of non-current borrowings
1 , 6 6 6 EUR
1,6 23 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.